ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $204,000 | -75.5% | 33,200 | -75.2% | 0.00% | -80.0% |
| Q2 2017 | $834,000 | +955.7% | 134,100 | +972.8% | 0.01% | +400.0% |
| Q1 2017 | $79,000 | -35.2% | 12,500 | -44.2% | 0.00% | 0.0% |
| Q2 2016 | $122,000 | -87.1% | 22,400 | -82.5% | 0.00% | -87.5% |
| Q1 2016 | $948,000 | +125.2% | 127,800 | +152.1% | 0.01% | +700.0% |
| Q4 2015 | $421,000 | -54.2% | 50,700 | -50.3% | 0.00% | -80.0% |
| Q3 2015 | $919,000 | -56.4% | 102,100 | -41.8% | 0.01% | -61.5% |
| Q2 2015 | $2,106,000 | +488.3% | 175,552 | +428.8% | 0.01% | +550.0% |
| Q1 2015 | $358,000 | – | 33,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |